Everolimus-d4 (C007B-153468)

Catalog No.: C007B-153468
Manufacturer No.: E338899-1mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Everolimus-d4 is a Rapamycin derivative and macrolide immunosuppressant. Everolimus-d4 inhibits cytokine-mediated lymphocyte proliferation.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Description
Specifications

Everolimus-d4 is a Rapamycin derivative and macrolide immunosuppressant. Everolimus-d4 inhibits cytokine-mediated lymphocyte proliferation.

Specifications and Purity: 80%Hplc，99atom%D

Molecular Formula: C53H79D4NO14

Molecular Weight: 962.25

PubChem CID: 57369482

Isomeric SMILES: [2H]C([2H])(C([2H])([2H])O[C@@H]1CC[C@H](C[C@H]1OC)C[C@@H](C)[C@@H]2CC(=O)[C@@H](C=C([C@H]([C@H](C(=O)[C@@H](C[C@@H](C=CC=CC=C([C@H](C[C@@H]3CC[C@H]([C@@](O3)(C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)O)C)OC)C)C)C)OC)O)C)C)O

Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/E338899-SCI_547b891c4cad5f0422182f9db6eedf1e.pdf

UPC:: 51152004
Condition:: New
HazmatClass:: No
WeightUOM:: LB
MPN:: E338899-1mg
CAS:: 1338452-54-2
Product Size:: 1mg
Hazard Statement Codes:: H372
Precautionary Statement Codes:: P270:P264:P260

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."